Plant-based systems are considered a valuable platform for the production of recombinant proteins as a result of their well-documented potential for the flexible, low-cost production of high-quality, bioactive products.
Seed 1 x 10
6 Sf9 cells per well in 2.5 ml Sf-900 medium containing 10% fetal bovine serum, 10 µg/ml gentamycin and 100 µM ganciclovir and infect with 100 µl of V1 stock in every well. 7. Incubate cells for 3 days at 27 °C. 8. Collect and centrifuge medium at 4,000 x g. 9. Store the supernatant (V2 high-titer stock) at 4 °C. 10 . Seed 1 x 10 6 Sf9 cells per well in 2.5 ml Sf-900 medium containing 10% fetal bovine serum, 10 µg/ml gentamycin and 100 µM ganciclovir and infect with 25 µl of V2 stock in every well. 11. Incubate cells for 3 days at 27 °C. 12. Collect cells by centrifuge at 4,000 x g and use insect cell pellet for protein extraction (step 3.1.2.1).
3. Nicotiana benthamiana transient expression systems:
1. Grow N. benthamiana plants in a greenhouse, under natural light within the temperature range 18-23 °C. For agroinfection use 4-5 week old plants. 2 . Keep agroinfected plants in a climate chamber at 22 °C with a 13 hr day/11 hr night photoperiod. 3. Commercial recombination cloning system:
1. Introduce pK7WG2.G65mut in Agrobacterium tumefaciens strain EHA105 electrocompetent cells as previously described 8 and screen the colonies, grown on LB medium containing rifampicin (50 µg/ml), streptomycin (300 µg/ml) and spectinomycin (100 µg/ml) after 2 days of incubation at 28 °C, by colony PCR 8 using the following transgene-specific primers: 5'-CATGGTGGAGCACGACACGCT-3' and 5'-CACACGCCGGCAGCAGGT-3', with an annealing temperature of 58 °C and an elongation time of 50 sec. Carry out the PCR reaction in a total volume of 20 µl. 2. Inoculate bacteria in 30 ml of LB medium containing rifampicin (50 µg/ml), streptomycin (300 µg/ml) and spectinomycin (100 µg/ ml) for two days at 28 °C. 3. Collect bacteria by centrifugation at 4,000 x g for 20 min and resuspend pellet in 10 ml of infiltration buffer (10 mM MES, 10 mM MgCl 2 , 100 µM acetosyringone, pH 5.6). Measure the OD 600 value and then adjust it to 0.9 by diluting in the same buffer. NOTE: the total volume needed for infiltrating three N. benthamiana plants is 30 ml. 4. Use a 2.5 ml needleless syringe to infiltrate the Agrobacterium suspension in N. benthamiana leaves. Carefully and slowly inject leaf panels with the suspension from the syringe. Infiltrate three expanded leaves per plant and use three plants as triplicates. NOTE: for health and safety reasons wear eye protection during infiltration process. 5. Collect agroinfiltrated leaves 2 days post infection (dpi) and freeze in liquid nitrogen. Store plant tissue at -80 °C.
MagnICON system:
1. Introduce the MagnICON vectors -the 5' module (pICH20111), the 3' module (pICH31070.G65mut), and the integrase module (pICH14011) -in A. tumefaciens GV3101 strain using standard techniques. Screen the colonies, grown on LB medium containing 50 µg/ml rifampicin and appropriate vector-specific antibiotic (50 µg/ml carbenicillin for pICH20111 and pICH14011, 50 µg/ml kanamycin for pICH31070), by colony PCR using specific primers for each vector. 2. Inoculate separately the three A. tumefaciens strains in 5 ml of LB medium containing 50 µg/ml rifampicin and appropriate vector-specific antibiotic and shake overnight at 28 °C. appropriate antibiotics (rifampicin 50 µg/ml, streptomycin 300 µg/ml, spectinomycin 100 µg/ml) and grow overnight at 28 °C in an orbital shaker set at 200 rpm. 3. Use 1 ml of the pre-culture to inoculate a 50 ml Agrobacterium culture in YEB medium plus antibiotics (rifampicin 50 µg/ml, streptomycin 300 µg/ml, spectinomycin 100 µg/ml) and grow for 24 hr, until the bacterial culture is saturated (OD 600 value of 0.5-1.0). 4. Collect bacteria by centrifugation at 4,000 x g for 20 min and resuspend pellet in 50 ml of liquid plant culture medium. Repeat this step twice to completely remove antibiotics. 5. Take first healthy fully expanded leaves from in vitro tobacco plants and cut them into approximately 1 cm squares. 6. Transfer leaf pieces to deep Petri dishes containing bacterial suspension and leave in the dark for 20 min. 7. Remove leaf pieces from suspension and blot dry on sterile filter paper. 8. Place leaf pieces with adaxial side (upper leaf surface) on solid plant culture medium containing 1.0 µg/ml 6-benzylaminopurine (BAP) and 0.1 µg/ml naphthalene acetic acid (NAA) and incubate plates for two days in a climate chamber at controlled conditions (25 °C, 16 hr day/8 hr night). 9. Transfer leaf pieces onto solid culture medium (including 1.0 µg/ml BAP, 0.1 µg/ml NAA, 500 µg/ml cefotaxime, 100 µg/ml kanamycin) with abaxial surface (lower surface of leaf) in contact with medium. 10. Incubate plates for 2-3 weeks in the climate chamber at 25 °C with 16 hr/8 hr day/night regime to induce shoot formation. Subculture every 2 weeks by transferring leaf explants to fresh solid plant culture medium containing 1.0 µg/ml BAP, 0.1 µg/ml NAA, 500 µg/ml cefotaxime and 100 µg/ml kanamycin. 11. When shoots appear transfer them to Magenta boxes containing solid culture medium including 500 µg/ml cefotaxime and 100 µg/ml kanamycin to induce root formation. Incubate plantlets with 16 hr day/8 hr night photoperiod at 25 °C for 1-2 weeks. 12. When roots form, transfer the plants to soil in the greenhouse.
. NOTE: Restricted areas should be designed for storage, handling and disposal of radioactive material.
Representative Results
An experimental design for the heterologous expression of a target recombinant protein in different production systems is described here. The first focus was the set-up of the different platforms by establishing the optimal conditions for the expression of the target protein in each system.
The expression of the target protein, hGAD65mut, was induced in triplicate E. coli cultures. Following 3 hr of expression at 37 °C, bacterial cells were collected by centrifugation and lysed by sonication. After a centrifugation step, soluble proteins were separated from insoluble inclusion bodies and initial analyses demonstrated that hGAD65mut accumulated prevalently in insoluble inclusion bodies (data not shown). Recombinant protein solubilisation required the use of urea 6 M, which, for its strong denaturing properties, interferes with RIA analysis, making impossible a proper quantification of hGAD65mut. Several strategies have been reported for limiting the formation of inclusion bodies, comprising growing the microbial cells at low temperature 11 . The cultures were grown at 15 °C and 20 °C, and recombinant protein expression was induced at the same temperatures. As shown in Figure 1A , the solubilisation of hGAD65mut produced at both temperatures, again requires urea (lanes S2). Thus, low temperatures in this experiment do not prevent hGAD65mut from forming insoluble aggregates.
Baculovirus vectors containing the hGAD65mut sequence (Baculo.G65mut) was expressed in adherent Sf9 cell cultures. V1 and V2 high-titer stocks were prepared and the best-performing infection conditions were set up evaluating different viral stock volumes from 5-50 μl. As shown in Figure 1B , the optimal viral stock volume was identified as 25 μl, yielding 11.8 ± 0.8 μg of recombinant protein per ml of culture medium, as evaluated by RIA analysis ( Table 1) .
Following infiltration, time course analysis of agroinfected N. benthamiana leaves was carried out in the two transient expression systems. For the pK7WG2-based system, leaf samples were pooled daily in the range 1-5 dpi, total soluble proteins (TSP) were extracted and equal amounts of TSP were analyzed by western blot (Figure 1C ). This analysis highlighted that the maximum accumulation of target recombinant protein is reached 2 dpi. Therefore, the leaves were harvested 2 dpi and the protein extracts were analyzed by RIA for measuring recombinant protein accumulation, which shows an average of 67.8 µg/g FLW (fresh leaf weight, Table 1 ). Recombinant protein expression levels, using this system, may be further improved, by co-infiltrating the leaves with a suppressor of Post-Transcriptional Gene Silencing (PTGS) like P19 or HC Pro 12 .
The same time-course detection was carried out with N. benthamiana leaves agroinfected with the MagnICON vectors: infected leaves were collected 1-8 dpi and equal amounts of TSP were analyzed by western blot. This analysis demonstrated that maximum recombinant protein accumulation is obtained 4 dpi ( Figure 1D) , with an average accumulation of the recombinant protein of 78.8 µg/g FLW ( Table 1) , as evaluated by RIA.
The expression of hGAD65mut in transgenic tobacco plants has been previously reported 12 , showing that recombinant protein levels varied significantly among independently transformed lines. The best-performing hGAD65mut T1 transgenic plant was self-crossed and the derived plants (T2) were analyzed to select again the best performing one. This procedure was repeated over several generations to develop a homogeneous production platform, checking the performance in each generation by RIA until no further improvement was achieved (data not shown). In Figure 1E , a representative western blot of T5 transgenic plants is reported, where the homogeneity of recombinant protein yields is evident. As shown in Figure 1F , the average hGAD65mut yield increased from T2 to T6, reaching level of 99.1 µg/g FLW ( Table 1 ) and, during the selection process, the standard deviation of the expression level declined. 
System [hGAD65mut] (µg/ml) [hGAD65mut]
Baculo/insect 117.5 ± 7.7 11.8 ± 0.8 µg/ml culture medium 
Elite T6
33.0 ± 3.8 99.1 ± 11.3 µg/g FLW Table 1 : hGAD65mut yields hGAD65mut yields in different platforms -fermenter-based (Baculo/Insect) and plant-based (pK7WG2-and MagnICON in N. benthamiana and elite T6 in N. tabacum). Second column -hGAD65mut concentration in protein extracts (µg/ml). Third column -hGAD65mut content in fresh leaf weight (µg/g FLW) for plant-based platforms and in cell culture medium (µg/ml) for fermenter-based platform.
Discussion
In this study three different platforms were compared for the expression of a recombinant human protein: bacterial cells, Baculovirus/insect cells and plants. The plant-based platform was further explored by exploiting three widely used expression technologies (i.e., transient -MagnICON and pK7WG2 based -and stable). The target protein chosen for this experiment, hGAD65mut, has been previously expressed in different systems 13 , and its production and functionality are easily detectable and measurable 14 .
Bacterial cells were not an effective production platform because hGAD65mut formed inclusion bodies, even at low-temperature growing conditions, thus requiring laborious solubilization and refolding to achieve its native conformation. Indeed, the main failure of this platform for the expression of complex recombinant proteins is the right conformation of the final product.
The Baculovirus/insect cell platform mediated a high expression of the immunoreactive recombinant protein, but the main limitation of this expression system is the high cost of the culture media, required to grow insect cells. It was estimated that total production costs for 1 g of hGAD65mut could reach 700 euro in this production platform (considering 9 L of insect cell culture media required). A further limitation of this expression platform is the need of sterile cultivation of insect cells, which requires personnel with aseptic manipulation skills. To ensure efficient recombinant protein accumulation two critical parameters must be carefully controlled in this expression system: the viral stock volumes used to infect cells and the timing of viral infection. Furthermore, the detergent, used for total soluble protein extraction from Sf9 insect cells, drastically influences recombinant protein solubilisation.
Plant-based systems were the most beneficial platform to express hGAD65mut: the plant-made recombinant protein was immunoreactive and accumulated at high levels in leaf tissues. Comparing different plant-based expression systems, the highest yields were achieved in stable transformed tobacco plants ( Table 1 ) and, if considering the total biomass of tobacco compared to N. benthamiana, used for transient expression, the overall higher productivity of tobacco is evident. However, the main limitation of stable transformed tobacco plant-based platform is the time required for the set-up of the system, which in our study took 20 months. Indeed, a homozygous line should be selected for recombinant protein expression homogeneity and it may require repeated self-cross cycles, starting from the highest T1 expressing lines. In particular, when the selected T1 bears more than one copy of the transgenic trait, the breeding program may take up to 3 years.
Transient expression systems offered the advantage of rapid upscaling due to a short interval between transformation and expression and the set-up of the expression platform required 4 days. However, a limitation of the plant-based transient systems is that their automation is hardly implementable on a lab-scale unless dedicated high-grade equipment for agro-infiltration is used. Hence, a proper calculation for the large-scale production of hGAD65 using transient-based systems cannot be performed here. On the other hand, we speculate that total production costs for 1 g of recombinant protein using T6 stable tobacco line may be calculated at less than 5 euro (considering soil for growing 60 tobacco plants). To ensure the efficient agroinfiltration and protein production several critical parameters should be carefully controlled (plant developmental stage, grow and infiltration condition of Agrobacterium), as previously reported 15 . Furthermore, for each expression experiment a specific time-course analysis should be performed to select the dpi that allows the highest accumulation of the recombinant protein.
The example discussed here can be considered a proof-of-principle case study, that highlights some of the specific advantages of plantbased production over traditional systems. In particular, tobacco transgenic lines homogeneously expressing the recombinant protein can be considered a valuable platform for the mass production of recombinant proteins that are required in large-quantities.
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